UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.676

Sortiert nach

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2017-07, Vol.28 (suppl_4), p.iv1-iv21

2017

Link zum Volltext

Verfügbarkeit prüfen

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v1-v27

2016

Link zum Volltext

Verfügbarkeit prüfen

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer

Radiotherapy and oncology, 2017-12, Vol.125 (3), p.439-444

2017

Link zum Volltext

Verfügbarkeit prüfen

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi89-vi98

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2008-03, Vol.70 (3), p.685-692

2008

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation

Annals of oncology, 2020-12, Vol.31 (12), p.1597-1598

2020

Link zum Volltext

Verfügbarkeit prüfen

Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands

Annals of oncology, 2012-10, Vol.23 (10), p.2743-2747

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Annals of oncology, 2020-06, Vol.31 (6), p.798-806

2020

Link zum Volltext

Verfügbarkeit prüfen

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Annals of oncology, 2014-08, Vol.25 (8), p.1462-1474

2014

Link zum Volltext

Verfügbarkeit prüfen

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

Annals of oncology, 2013-06, Vol.24 (6), p.1543-1548

2013

Link zum Volltext

Verfügbarkeit prüfen

Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107532-107532, Article 107532

2024

Link zum Volltext

Verfügbarkeit prüfen

SP-0008 STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AS STANDARD IN EARLY-STAGE NSCLC

Radiotherapy and oncology, 2012-05, Vol.103, p.S3-S3

Senan, S

2012

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer

Radiotherapy and oncology, 2024-05, Vol.194, p.110147-110147, Article 110147

2024

Link zum Volltext

Verfügbarkeit prüfen

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

Annals of oncology, 2020-02, Vol.31 (2), p.191-201

2020

Link zum Volltext

Verfügbarkeit prüfen

256 INVITED Intensity Modulated Radiotherapy: Fixed-Beam and Arc Delivery Techniques for Locally Advanced Disease

European journal of cancer (1990), 2011, Vol.47, p.S60-S60

Senan, S

2011

Link zum Volltext

Verfügbarkeit prüfen

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy

Radiotherapy and oncology, 2023-10, Vol.187, p.109823-109823, Article 109823

2023

Link zum Volltext

Verfügbarkeit prüfen

ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

Annals of oncology, 2019-04, Vol.30, p.ii25-ii25

2019

Link zum Volltext

Verfügbarkeit prüfen

Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2016-04, Vol.94, p.108-113

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Annals of oncology, 2011-05, Vol.22 (5), p.1154-1163

2011

Link zum Volltext

Verfügbarkeit prüfen

Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors

International journal of radiation oncology, biology, physics, 2018-03, Vol.100 (3), p.738-747

2018

Link zum Volltext

Verfügbarkeit prüfen

Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

Annals of oncology, 2019-04, Vol.30, p.ii27-ii28

2019

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2023-08, Vol.182, p.107294-107294, Article 107294

2023

Link zum Volltext

Verfügbarkeit prüfen

Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy

Annals of oncology, 2015-10, Vol.26 (10), p.2196-2196

2015

Link zum Volltext

Verfügbarkeit prüfen

Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-01, Vol.30 (1), p.17-22

2018

Link zum Volltext

Verfügbarkeit prüfen

The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma

Radiotherapy and oncology, 2021-03, Vol.156, p.223-230

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.676

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.407)
Mit Volltextzugriff
(1.553)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(903)
Life Sciences & Biomedicine
(664)
Humans
(472)
Oncology
(355)
Hematology, Oncology And Palliative Medicine
(206)
Female
(198)
Male
(194)
Radiology, Nuclear Medicine & Medical Imaging
(186)
Technology
(166)
Lung Neoplasms - Pathology
(145)
Physical Sciences
(143)
Middle Aged
(138)
Aged
(131)
Lung Neoplasms - Radiotherapy
(124)
Radiology
(121)
Biological And Medical Sciences
(108)
Neoplasm Staging
(107)
Carcinoma, Non-Small-Cell Lung - Pathology
(102)
Adult
(100)
Respiratory System
(97)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer

Pulmonary toxicity in patients treated with immune checkpoint inhibitors and radiation

Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017

SP-0008 STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AS STANDARD IN EARLY-STAGE NSCLC

Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

256 INVITED Intensity Modulated Radiotherapy: Fixed-Beam and Arc Delivery Techniques for Locally Advanced Disease

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy

ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)

Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors

Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer

Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy

Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands

The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma

Suchergebnisse filtern